Immunohistochemical findings in primary fallopian tube cancer. Case report

European Journal of Gynaecological Oncology

Volumn 31, Issue 1, 2010, Pages 120-122

  Raba, G ^a   Laudanski, P ^b   Kanczuga Koda, L ^b  

^a Provincial Hospital   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

CK20; CK7; ER ; ER ; Oncogenes; Primary fallopian tube cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; CONTRAST MEDIUM; CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

AGED; APPENDECTOMY; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CASE REPORT; DISEASE DURATION; ECHOGRAPHY; FEMALE; FEMALE GENITAL SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LOWER ABDOMINAL PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; OMENTUM; PERITONEUM ADHESION; PROTEIN EXPRESSION; UTERINE TUBE CARCINOMA;

AGED; CARCINOMA, PAPILLARY; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; RECEPTORS, PROGESTERONE;

EID: 77349110455     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Juretzka M., Hensley M.L., Tew W., Konner J., Aghajanian C., Leitao M. et al.: "A phase 2 trial of oral imatinib in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma in second or greater remission". Eur. J. Gynaecol. Oncol., 2008, 29, 568.
2. Nappi L., Indraccolo U., Matteo M., Rosenberg P., Greco P.: "Malignant mixed mullerian tumor of the fallopian tube coincident with a primary serous carcinoma of the ovary. Case report". Eur. J. Gynaecol. Oncol., 2007, 28, 511.
3. Stewart S.L., Wike J.M., Foster S.L., Michaud F.: "The incidence of primary fallopian tube cancer in the United States". Gynecol. Oncol., 2007, 107, 392.
4. Moore K.N., Moxley K.M., Fader A.N., Axtell A.F., Rocconi R.P., Abaid L.N. et al.: "Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary". Gynecol. Oncol., 2007, 107, 398.
5. Verit F.F., Kafali H.: "Primary carcinoma of the fallopian tube mimicking tubo-ovarian abscess". Eur. J. Gynaecol. Oncol., 2005, 26, 225.
6. Riska A., Leminen A.: "Updating on primary fallopian tube carcinoma". Acta Obstet. Gynecol. Scand., 2007, 86, 1419.
7. Mahajan N.N.: "Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation". Cancer, 2007, 110, 2819.
8. Callahan M.J., Crum C.P., Medeiros F., Kindelberger D.W., Elvin J.A., Garber J.E. et al.: "Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction". J. Clin. Oncol., 2007, 25, 3985.
9. Nowee M.E., Dorsman J.C., Piek J.M., Kosma V.M., Hamalainen K., Verheijen R.H.M., Van Diest P.J.: "HER-2/neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study". Histopathology, 2007, 51, 666.
10. Brandenberger A.W., Tee M.K., Jaffe R.B.: "Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues". J. Clin. Endocrinol. Metab., 1998, 83, 1025.
11. Pujol P., Rey J.M., Nirde P., Roger P., Gastaldi M., Laffargue F. et al.: "Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis". Cancer Res., 1998, 58, 5367.
12. Baker P.M., Oliva E.: "Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update". Int. J. Gynecol. Pathol., 2005, 24, 39.